The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

A groundbreaking study by researchers at Weill Cornell Medicine and epigenetics company TruDiagnostic has unveiled new DNA markers associated with retroelements—remnants of ancient viral genetic ...

Shorter telomeres are linked to higher risks of stroke, dementia, and depression, but lifestyle factors may help counteract ...

The study titled “Consanguine Marriage leads to Hierarchical Imbalance of ABO and STR Frequency and affects the Genetic ...

Subscribe today and save an extra 5% with checkout code 'LOVE5' Engaging articles, amazing illustrations & exclusive interviews Issues delivered straight to your door or device ...

Fathers exposed to high stress in childhood had different epigenetic markers that may affect their offspring, though more research is needed.

Our genes contain all the instructions our body needs to function, but their expression must be finely regulated to guarantee ...

Researchers have discovered that DNA and RNA epigenetics form a complementary system that precisely regulates gene activity, ...

Symptoms of Huntington's disease appear late in life. Research reveals how DNA repeats grow toxic over time, explaining the ...

Aging involves complex cellular and molecular changes, including epigenetic modifications like Deoxyribonucleic acid (DNA) methylation and histone marks. Age predictors, or "clocks," have been ...

Emerging drug-resistant strains are posing significant challenges to the global fight against tuberculosis (TB) and it is a critical task to detect treatment failure as early as possible.

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.